0001209191-19-034726.txt : 20190605
0001209191-19-034726.hdr.sgml : 20190605
20190605161510
ACCESSION NUMBER: 0001209191-19-034726
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190604
FILED AS OF DATE: 20190605
DATE AS OF CHANGE: 20190605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RAZIN SHELDON
CENTRAL INDEX KEY: 0000903440
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12537
FILM NUMBER: 19879865
MAIL ADDRESS:
STREET 1: C/O QUALITY SYSTEMS INC
STREET 2: 18111 VON KARMAN AVE SUITE 700
CITY: IRVINE
STATE: CA
ZIP: 92612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEXTGEN HEALTHCARE, INC.
CENTRAL INDEX KEY: 0000708818
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
IRS NUMBER: 952888568
STATE OF INCORPORATION: CA
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 18111 VON KARMAN AVENUE
STREET 2: SUITE 800
CITY: IRVINE
STATE: CA
ZIP: 92612
BUSINESS PHONE: 949-255-2600
MAIL ADDRESS:
STREET 1: 18111 VON KARMAN AVENUE
STREET 2: SUITE 800
CITY: IRVINE
STATE: CA
ZIP: 92612
FORMER COMPANY:
FORMER CONFORMED NAME: QUALITY SYSTEMS, INC
DATE OF NAME CHANGE: 20180823
FORMER COMPANY:
FORMER CONFORMED NAME: NEXTGEN HEALTHCARE, INC
DATE OF NAME CHANGE: 20180823
FORMER COMPANY:
FORMER CONFORMED NAME: QUALITY SYSTEMS, INC
DATE OF NAME CHANGE: 20100804
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-04
0
0000708818
NEXTGEN HEALTHCARE, INC.
NXGN
0000903440
RAZIN SHELDON
18111 VON KARMAN AVENUE
SUITE 800
IRVINE
CA
92612
1
0
1
0
Common Stock
2019-06-04
4
S
0
20000
19.05
D
10225834
D
Common Stock
2019-06-04
4
S
0
12301
19.40
D
10213533
D
Common Stock
2019-06-04
5
G
0
E
25000
0.00
D
10188533
D
Sale prices for the transactions reported here range from $19.03 to $19.13. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its stockholders upon request.
Sale prices for the transactions reported here range from $19.40 to $19.41. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its stockholders upon request.
Transaction comprises a gift to The Sheldon Razin Family Foundation, a non-profit foundation.
/s/ James W. Sytsma, Attorney-in-Fact for Sheldon Razin
2019-06-05